Shares of Tilray (TLRY) rallied in after-hours trading Tuesday, rising nearly 13%. Driving the medical cannabis maker’s stock was the news that the …
It’s a very rewarding trading day for investors in Biocept (BIOC) with shares up nearly 80%, making the stock Wall Street’s bull of …
Proteostasis Therapeutics (PTI) announced today a worldwide, exclusive license agreement with Genentech for the rights to a potential new therapy, without revealing what …
The 2018 Farm Bill, which passed Congress is now headed to the desk of President Trump and if he signs it, hemp farms …
MYOS RENS Technology (MYOS) stock is soaring — up over 50% since news broke today that The Vitamin Shoppe is picking up its product …
Investing in the marijuana industry may have seemed taboo a few years back, but as more states are making recreational marijuana legal with …
Israeli generic drug manufacturer Teva (TEVA) was named by the Washington Post as being one of more than a dozen subjects of a …
Marinus Pharmaceuticals (MRNS) just released positive results from its Phase 2 clinical trials, which evaluated ganaxolone intravenous (IV) (called the Magnolia Study) and …
Blogger Christiana Friedman says the FDA decision for Amarin’s (AMRN) drug Vascepa might not be the make or break for the company. In …
Shares of biotechnology company AcelRx (ACRX) are tumbling – down nearly 17% as of this writing. The reason?
